Plunkett Research Online: La Jolla Pharmaceutical Company

LA JOLLA PHARMACEUTICAL COMPANY (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

La Jolla Pharmaceutical Company is a biopharmaceutical firm focused on the discovery, development and commercialization of therapeutic products for patients with life-threatening diseases. La Jolla’s product portfolio consists of: GIAPREZA, the firm’s proprietary formulation of angiotensin II as an.....


LA JOLLA PHARMACEUTICAL COMPANY

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617-715-3600
Fax:
Address: 201 Jones Rd., Ste. 400
Waltham, MA 02451 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Innoviva Inc

Contacts Description

Larry EdwardsCEO/Pres.
Michael HearneCFO/Chief Accounting Officer
See More
La Jolla Pharmaceutical Company is a biopharmaceutical firm focused on the discovery, development and commercialization of therapeutic products for patients with life-threatening diseases. La Jolla’s product portfolio consists of: GIAPREZA, the firm’s proprietary formulation of angiotensin II as an.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture